PROVIREX´s development of nanobody-rAAV-mediated administration of recombinases to T cells in humans. Recombinase RecHTLV removes HTLV-1 proviruses from the genome of infected cells.
My German Pavilion
- Manage your personal profile here and enter your desired business contacts to German companies
- Keep an eye on the trade fairs, German exhibitors and products that are of interest to you
- Receive an e-mail notification on relevant upcoming German trade fair presentations